Viewing data from:

ALTAVERA

ANDA

ETHINYL ESTRADIOL; LEVONORGESTREL | A079102 | XIROMED PHARMA ESPANA SL

1 strength0 unique patents0 unique exclusivities

Medicare Part D Spending

CMS annual spending data for Altavera (2023)

Total Spending

$80K

Total Claims

3,209

Beneficiaries

759

Avg Cost/Unit

$0.42

Spending Trend

$27K(2019)→$30K(2020)→$78K(2021)→$86K(2022)→$80K(2023)

YoY Change:-2.5%

5yr CAGR:-6.0%

Source: CMS Medicare Part D Spending by Drug (2023). Shows gross drug cost under Part D.

Products (1)

#001 — 0.03MG;0.15MG

0 patents0 exclusivities▴

TABLET;ORAL-28 | Approved: Aug 3, 2010

No patent or exclusivity listings for this strength.